Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
File(s)s41467-023-40561-x.pdf (232.12 KB)
Published version (correction)
Author(s)
Type
Journal Article
Date Issued
2023-08-07
Date Acceptance
2023-08-01
Citation
Nature Communications, 2023, 14 (1), pp.1-1
ISSN
2041-1723
Publisher
Nature Portfolio
Start Page
1
End Page
1
Journal / Book Title
Nature Communications
Volume
14
Issue
1
Copyright Statement
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/37550302
PII: 10.1038/s41467-023-40561-x
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2023-08-07